Insights

Expanding Oncology Portfolio Helsinn's strong focus on supportive care and oncology, combined with recent investments in FGFR tyrosine kinase inhibitor development, presents opportunities to collaborate on innovative cancer treatments and expand their product offerings.

Global Market Reach With a commercial presence in about 90 countries and strategic partnerships like Fosun Pharma in China, there are significant opportunities to support Helsinn in deploying new products across diverse healthcare markets.

Focus on Oncology Support Helsinn's emphasis on oncology supportive care products, such as Akynzeo, suggests a strong demand for specialized medication solutions, opening avenues to introduce complementary drugs or supportive care devices.

Innovation & R&D Growth The establishment of a dedicated R&D hub in the U.S. to develop FGFR inhibitors indicates a potential for partnership in clinical trials, research services, or distribution of new oncology therapeutics.

Strategic Expansion Recent executive appointments and partnership growth highlight Helsinn's commitment to strengthening its market position, creating opportunities for business development efforts focused on new product launches and geographic expansion.

Similar companies to Helsinn Group

Helsinn Group Tech Stack

Helsinn Group uses 8 technology products and services including Google Cloud, Office 365, LinkedIn, and more. Explore Helsinn Group's tech stack below.

  • Google Cloud
    Infrastructure As A Service
  • Office 365
    Office Suites
  • LinkedIn
    Online Community Software
  • Microsoft Azure
    Platform As A Service
  • C#
    Programming Languages
  • Vimeo
    Video Players
  • Nginx
    Web Servers
  • Apache
    Web Servers

Media & News

Helsinn Group's Email Address Formats

Helsinn Group uses at least 1 format(s):
Helsinn Group Email FormatsExamplePercentage
First.Last@helsinn.comJohn.Doe@helsinn.com
98%
LF@helsinn.comDJ@helsinn.com
1%
FL@helsinn.comJD@helsinn.com
1%

Frequently Asked Questions

What is Helsinn Group's phone number?

Minus sign iconPlus sign icon
You can contact Helsinn Group's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Helsinn Group's official website and social media links?

Minus sign iconPlus sign icon
Helsinn Group's official website is helsinn.com and has social profiles on LinkedInCrunchbase.

How much revenue does Helsinn Group generate?

Minus sign iconPlus sign icon
As of December 2025, Helsinn Group's annual revenue is estimated to be $13M.

What is Helsinn Group's SIC code NAICS code?

Minus sign iconPlus sign icon
Helsinn Group's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Helsinn Group have currently?

Minus sign iconPlus sign icon
As of December 2025, Helsinn Group has approximately 364 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Cmo Planner: E. L.Chief Strategy Officer: E. M.Vp And Head, Medical & Scientific Affairs: W. B.. Explore Helsinn Group's employee directory with LeadIQ.

What industry does Helsinn Group belong to?

Minus sign iconPlus sign icon
Helsinn Group operates in the Pharmaceutical Manufacturing industry.

What technology does Helsinn Group use?

Minus sign iconPlus sign icon
Helsinn Group's tech stack includes Google CloudOffice 365LinkedInMicrosoft AzureC#VimeoNginxApache.

What is Helsinn Group's email format?

Minus sign iconPlus sign icon
Helsinn Group's email format typically follows the pattern of First.Last@helsinn.com. Find more Helsinn Group email formats with LeadIQ.

How much funding has Helsinn Group raised to date?

Minus sign iconPlus sign icon
As of December 2025, Helsinn Group has raised $7M in funding. The last funding round occurred on May 24, 2018 for $7M.

When was Helsinn Group founded?

Minus sign iconPlus sign icon
Helsinn Group was founded in 1976.

Helsinn Group

Pharmaceutical ManufacturingTicino, Switzerland201-500 Employees

Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology, and dermato-oncology. 

Founded in 1976, Helsinn has nearly 50 years of experience in the pharmaceutical industry, with an extensive network of long-standing trusted partners enabling a commercial presence in about 90 countries. 
Helsinn Healthcare SA, headquartered in Lugano (Switzerland), oversees the activities of the three Helsinn Group’s subsidiaries (Helsinn Birex Pharmaceuticals Ltd., Helsinn Therapeutics (U.S.), Inc., Helsinn Pharmaceuticals (Beijing) Co., Ltd.), defining and implementing the Group’s strategy.

Our mission is to champion and support patients with cancer and chronic diseases at every stage of their journey, by providing them with the best medications and solutions based on their needs and preferences.

Follow our LinkedIn page to stay updated with news from Helsinn Group! 
If you are interested in joining us, please visit our website (www.helsinn.com): applications should only be submitted via the appropriate country portal, available under “Careers – Join us” website section.

* This account shall only be used to share news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1976
Employees
201-500

Section iconFunding & Financials

  • $7M

    Helsinn Group has raised a total of $7M of funding over 1 rounds. Their latest funding round was raised on May 24, 2018 in the amount of $7M.

  • $25M$50M

    Helsinn Group's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $7M

    Helsinn Group has raised a total of $7M of funding over 1 rounds. Their latest funding round was raised on May 24, 2018 in the amount of $7M.

  • $25M$50M

    Helsinn Group's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.